As of Mar 31
| +0.17 / +1.62%|
The 5 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 15.00, with a high estimate of 20.00 and a low estimate of 11.00. The median estimate represents a +40.32% increase from the last price of 10.69.
The current consensus among 6 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.